Therapy-induced tumor immunosurveillance involves IFN-producing killer dendritic cells.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 17283111.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A unique class of IFN-producing killer dendritic cells (IKDC) resembling natural killer cells has been defined that can recognize and lyse tumor cells through a tumor necrosis factor-related apoptosis-inducing ligand-dependent mechanism. IKDC may mediate the host-dependent antitumor activity of Gleevec/STI571 and other therapeutics that can inhibit the c-kit tyrosine kinase. IKDC represent an important new component of the innate immune system responding to cancer.
Medical subject headings
- Dendritic Cells
- Interferon-gamma
- Neoplasms, Experimental